Price
Target price
€1.96
€1.96
1.760%
0.0338
1.760%
€17.16
03.10.25 / Tradegate
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Iovance Biotherapeutics Inc. Stock
Iovance Biotherapeutics Inc. gained 1.760% today.
We see a rather positive sentiment for Iovance Biotherapeutics Inc. with 17 Buy predictions and 2 Sell predictions.
Based on the current price of 1.96 € the target price of 17 € shows a potential of 769.21% for Iovance Biotherapeutics Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Iovance Biotherapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 1.760% | 8.764% | 3.394% | -77.535% | -71.680% | -79.214% | -92.728% |
| Ironwood Pharmaceuticals | 2.290% | 15.517% | 28.846% | -64.171% | -68.095% | -87.248% | -82.368% |
| Novocure Ltd | 3.500% | 12.182% | 19.112% | -5.981% | -57.624% | -84.300% | -87.226% |
| Arrowhead Pharmaceuticals Inc. | 3.250% | 8.809% | 27.925% | 78.735% | 64.964% | -10.185% | -18.499% |
Comments
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $14.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Chardan Capital from $25.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
